Evidence map›Paper›PMID 31280709›Full record

ArticleTrends in hearing

Direct-to-Consumer Hearing Devices: Capabilities, Costs, and Cosmetics.

Ibrahim Almufarrij, Kevin J Munro, Piers Dawes, Michael A Stone, Harvey Dillon

Abstract read
In one paragraph

Article in Trends in hearing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Participant valued appearance of bone conduction devices: a comparison between percutaneous and transcutaneous systems.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Hearables as a Gateway to Hearing Health Care.Clinical and experimental otorhinolaryngology · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ibrahim Almufarrij1 Manchester Centre for Audiology and Deafness, School of Health Sciences, UK.ORCID 0000-0003-4043-7234
Kevin J Munro1 Manchester Centre for Audiology and Deafness, School of Health Sciences, UK.
Piers Dawes1 Manchester Centre for Audiology and Deafness, School of Health Sciences, UK.
Michael A Stone1 Manchester Centre for Audiology and Deafness, School of Health Sciences, UK.ORCID 0000-0003-2252-9258
Harvey Dillon1 Manchester Centre for Audiology and Deafness, School of Health Sciences, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct-to-consumer (DTC) hearing devices can be purchased without consulting a hearing health professional. This project aims to compare 28 DTC devices with the most popular hearing aid supplied by the U.K. National Health Service (NHS). The comparison was based on technical performance, cosmetic acceptability, and the ability to match commonly used gain and slope targets. Electroacoustic performance was evaluated in a 2-cc coupler. Match to prescription target for both gain and slope was measured on a Knowles Electronic Manikin for Acoustic Research using a mild and also a moderate sloping hearing loss. Using an online blinded paired comparison of each DTC and the NHS reference device, 126 participants (50 were hearing aid users and 76 were nonhearing aid users) assessed the cosmetic appearance and rated their willingness-to-wear the DTC devices. The results revealed that higher purchase prices were generally associated with a better match to prescribed gain-frequency response shapes, lower distortion, wider bandwidth, better cosmetic acceptability, and higher willingness-to-wear. On every parameter measured, there were devices that performed worse than the NHS device. Most of the devices were rated lower in terms of aesthetic design than the NHS device and provided gain-frequency responses and maximum output levels that were markedly different from those prescribed for commonly encountered audiograms. Because of the absence or inflexibility of most of the devices, they have the potential to deliver poor sound quality and uncomfortably loud sounds. The challenge for manufacturers is to develop low-cost products with cosmetic appeal and appropriate electroacoustic characteristics.

Indexed as

Hearing AidsCosmeticsFemaleHumansMalePatient PreferenceState MedicineCosmeticsdirect-to-consumergainhearing aidspersonal sound amplification productsslope

Identifiers

PMID31280709
PMCPMC6614949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.